ArticlePregnancy (Hoboken, N.J.)2026
Standardized postpartum blood pressure protocol and lower rates of hypertension at 6 weeks postpartum.
Article in Pregnancy (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertensive disorders of pregnancy (HDP) increase the risk of chronic hypertension (HTN) and cardiovascular (CV) disease later in life. It is unknown how strict blood pressure (BP) monitoring postpartum (PP) may affect rates of HTN at 6 weeks PP. Objective: We evaluate the effect of a PP HTN standardized clinical assessment and management plan (SCAMP) on HTN at 6 weeks PP. Study design: This is a secondary analysis of a prospective cohort study of patients with PP HTN at a quaternary care center for 6 months after enacting an institution-wide SCAMP. The prospective group was compared with historical controls who delivered prior to initiation of the SCAMP. The SCAMP included (1) initiation or uptitration of medication for any BP ≥150/100 or any 2 BPs ≥140/90 within a 24-h period with a goal of BP <140/90 12 h prior to discharge and (2) enrollment in a remote BP monitoring system upon discharge. Inclusion criteria were an existing diagnosis of chronic HTN or HDP and a documented BP at a 6-week PP visit. The primary outcome was HTN, defined as systolic BP (SBP) ≥140 or diastolic BP (DBP) ≥90, at 6 weeks PP. Secondary outcomes included mean BP values as measured in the outpatient setting at 6 weeks PP and use of anti-HTNs at the time of the 6-week PP visit. For all analyses, Results: Of 780 PP HTN patients in the prospective cohort study, 627 (80.4%) met inclusion criteria for the secondary analysis, 305 in the SCAMP cohort and 322 historical controls. The SCAMP cohort had lower rates of chronic HTN, more patients on anti-HTNs, and higher rate of nifedipine use. The primary outcome of HTN at 6 weeks PP was significantly lower in the SCAMP group (10.5% vs. 18.3%, Conclusion: Implementation of a SCAMP was associated with reduced rates of HTN at 6 weeks PP, with lower mean SBP and DBP. More data are needed to evaluate how these findings mitigate long-term HTN risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.